21 Epstein-Barr virus infection and oncogenesis: B-cell diseases, T-cell malignancies, and risk factors
✍ Scribed by T. Osato; F. Mizuno; S. Imai; T. Aya; S. Koizumi; T. Kinoshita; Htay Kyi; H. Kikuta; M. Okano; S. Matsumoto; A. Matsuura; M. Sugiura; T. Miyazaki; W. Abo; T. Yamanaka; S. Chiba; T. Nakao; Y. Harabuchi; A. Kataura; M. Miwa; H. Ohigashi; K. Koshimizu; Y. Agishi
- Book ID
- 119104228
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 147 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0165-4608
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epstein‐Barr virus (EBV)‐associated post‐transplant lymphoproliferative disease (PTLD) arises in up to 10% of organ transplant recipients and is fatal in ∼50% of cases. PTLD can be modeled in SCID mice using EBV+ve human B lymphoblastoid cell lines (BLCLs), and the current study investi
of Lymphoid Ma I i g n a ncies BACKGROUND. The Epstein-Barr virus (EBV) has been frequently detected in lymphoid malignancies. However, EBV infectioii in the nonneoplastic cells of lymphoid malignancies has not been extensively studied. ## METHODS. Four hundred nine cases of lymphoid malignancies